September 18, 2020
Japanese ophthalmology powerhouse Santen Pharmaceutical has acquired US eye drug player Eyevance Pharmaceuticals Holdings for US$225 million, hoping the deal will help speed up its efforts to forge a stand-alone sales system in the world’s largest market. Santen and Eyevance...read more